BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deng M, Liu B, Zhang Z, Chen Y, Wang Y, Wang X, Lv Q, Yang X, Hou K, Che X, Qu X, Liu Y, Zhang Y, Hu X. Loss of G-protein-signaling modulator 2 accelerates proliferation of lung adenocarcinoma via EGFR signaling pathway. Int J Biochem Cell Biol 2020;122:105716. [PMID: 32058048 DOI: 10.1016/j.biocel.2020.105716] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yuan C, Bai R, Gao Y, Jiang X, Li S, Sun W, Li Y, Huang Z, Gong Y, Xie C. Effects of MicroRNA-195-5p on Biological Behaviors and Radiosensitivity of Lung Adenocarcinoma Cells via Targeting HOXA10. Oxid Med Cell Longev 2021;2021:4522210. [PMID: 34925694 DOI: 10.1155/2021/4522210] [Reference Citation Analysis]
2 Xu D, Wang Y, Zhou K, Wu J, Zhang Z, Zhang J, Yu Z, Liu L, Liu X, Li B, Zheng J. Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosis. Biosci Rep 2020;40:BSR20201087. [PMID: 33169793 DOI: 10.1042/BSR20201087] [Reference Citation Analysis]
3 Dang HH, Ta HDK, Nguyen TTT, Anuraga G, Wang CY, Lee KH, Le NQK. Identifying GPSM Family Members as Potential Biomarkers in Breast Cancer: A Comprehensive Bioinformatics Analysis. Biomedicines 2021;9:1144. [PMID: 34572330 DOI: 10.3390/biomedicines9091144] [Reference Citation Analysis]
4 Deng M, Tong R, Zhang Z, Wang T, Liang C, Zhou X, Hou G. EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma. Cancer Cell Int 2021;21:535. [PMID: 34645436 DOI: 10.1186/s12935-021-02226-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]